Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.

ABSTRACT:

Background

Although treatment decisions for localized prostate cancer (LPC) are preference-sensitive, the extent to which individuals with LPC receive preference-concordant treatment is unclear. In a sample of individuals with LPC, the purpose of this study was to (a) assess concordance between the influence of potential adverse treatment outcomes and treatment choice; (b) determine whether receipt of a decision aid predicts higher odds of concordance; and (c) identify predictors of concordance from a set of participant characteristics and influential personal factors.

Methods

Participants reported the influence of potential adverse treatment outcomes and personal factors on treatment decisions at baseline. Preference-concordant treatment was defined as (a) any treatment if

SUBMITTER: Pozzar RA 

PROVIDER: S-EPMC9404592 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature